Kim R Tsuchimoto
Director at Monopar Therapeutics (MNPR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 28SEC | MNPRMonopar Therapeutics | Sell Plan | 4853,605 held (−12%) | $108.83 | $53K | -27.4% |
| Aug 28SEC | MNPRMonopar Therapeutics | Sell Plan | 6152,990 held (−17%) | $109.56 | $67K | -27.9% |
| Aug 28SEC | MNPRMonopar Therapeutics | Sell Plan | 7002,290 held (−23%) | $110.65 | $77K | -28.6% |
| Aug 28SEC | MNPRMonopar Therapeutics | Sell Plan | 1,0981,192 held (−48%) | $111.84 | $123K | -29.4% |
| Aug 28SEC | MNPRMonopar Therapeutics | Sell Plan | 602590 held (−51%) | $112.93 | $68K | -30.1% |
| Aug 28SEC | MNPRMonopar Therapeutics | Sell Plan | 590 | $113.84 | $67K | -30.6% |
| Aug 27SEC | MNPRMonopar Therapeutics | Sell Plan | 48511,001 held (−4%) | $108.83 | $53K | -27.4% |
| Aug 27SEC | MNPRMonopar Therapeutics | Sell Plan | 61510,386 held (−6%) | $109.56 | $67K | -27.9% |
| Aug 27SEC | MNPRMonopar Therapeutics | Sell Plan | 7009,686 held (−7%) | $110.65 | $77K | -28.6% |
| Aug 27SEC | MNPRMonopar Therapeutics | Sell Plan | 1,0988,588 held (−11%) | $111.84 | $123K | -29.4% |
| Aug 27SEC | MNPRMonopar Therapeutics | Sell Plan | 6027,986 held (−7%) | $112.93 | $68K | -30.1% |
| Aug 27SEC | MNPRMonopar Therapeutics | Sell Plan | 5907,396 held (−7%) | $113.84 | $67K | -30.6% |
- Sell
Director Kim R Tsuchimoto sold $53K of MNPR at $108.83 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Kim R Tsuchimoto sold $67K of MNPR at $109.56 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Kim R Tsuchimoto sold $77K of MNPR at $110.65 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Kim R Tsuchimoto sold $123K of MNPR at $111.84 — cuts the stake by 48%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Kim R Tsuchimoto sold $68K of MNPR at $112.93 — cuts the stake by 51%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Kim R Tsuchimoto sold $67K of MNPR at $113.84 — pre-scheduled 10b5-1 plan sale.